84 results about "Drug identification" patented technology

A medication delivery and monitoring system and methods whereby drugs are safely delivered to a patient, monitored in real-time during delivery and crucial events are recorded during delivery to provide real-time, on-line information and detail for an audit trail. A novel safety label cradle unit is disclosed. Safety label cradles (SLC's) are provided in a plurality of sizes to match varying sizes of syringes which are disposed on a cradle of the SLC to provide a constant needle height on the SLC unit independent of syringe volume (barrel diameter). A selected SLC is securely affixed to a syringe by an adhesively backed label wrapping. The label is preprinted to provide drug identification indicia and drug preparation information. The information is automatically read into the system from the label. A novel delivery station of the system monitors drug delivery as a plunger of the syringe is pushed to deliver a drug to a patient. A smart tray in cooperation with a slider portion of the SLC is used to selectively deliver drugs to a port in the IV set. The smart tray comprises a first portion for carrying SLC units, an attachable second portion having a control panel for operating the system and a cover for lockably affixing the SLC units to the tray.

A prescription creation software system implemented on a computer is provided. The prescription creation software system includes a prescription creation screen display to allow the data capture of information including, patient-identifying data, prescribed drug identification data and drug quantification data. The prescription creation software system additionally provides a prescriber with drug formulary information identifying at least one drug as a patient's drug formulary preference, prior to completion of the prescription.

A pharmacy post office receives prescriptions and produces through an automated pill dispensing and packaging system, pharmacy letters that are sorted and delivered as first class or priority mail pieces. The system packages the prescription medication in carriers that are sized to fit into mail sorting machines that sort the first class or priority mail pieces by postal delivery routes. The pharmacy letters include patient mailing address information such that the pharmacy letters are then fed to the mail sorting machines and sorted along with the first class or priority mail pieces for delivery by the postal delivery persons along their customary routes. The system includes a robotic subsystem that dispenses the medication from pill canisters supplied by the drug companies and provides the pills to an automated packaging system. The packaging system feeds the pills into compartments of a carrier base or blister pack and prints on the carrier or applies as labels thereto drug identification information, mailing address information and tracking information, such as a machine readable code. The packaging system then assembles and seals the carrier, such that mailing address information is available for reading by mail sorting machines. The assembled pharmacy letters are then supplied to the mail sorting machines and included in the first class or priority delivery operations of the post office. A track and trace system may be included to provide a delivery schedule to the patient and/or prescribing doctor. The track and trace system is informed when the packaging system provides a pharmacy letter to the mail sorting machines, and the system determines if the pharmacy letter will be included in the same day postal delivery operations or in the next day operations. When a pharmacy letter is delivered by the postal delivery person, he or she scans the tracking code and transmits information back to the system, which then updates its delivery schedule to show the completed delivery.

The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. The system and method may utilize a sensor used for other physiologic monitoring to identify the drug. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary. The system and method also utilizes data collected from the patient with a physiological monitor or a ventilator sensor to further determine whether the drug is appropriate for the patient. The method and system may also include an override system for medical personnel. The method described may be carried out by a software application.

The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,15β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.

The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17α-ethynylandrost-5-ene-3β,11β,7α,17β-tetrol, 4α-acetoxy-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 17α-ethynylandrost-5-ene-3β,4β,7α,17β-tetrol, 17α-ethynylandrost-5-ene-3α,4β,7α,17β-tetrol and 17α-ethynylandrost-5-ene-3α,4β,17β-triol-7-one.

This system of identification and labeling is set on the container or package of drugs and contains drug identification units for the identification of the drug name, including identification units of manufacturing batch number and time. The identification unit of manufacturing batch number is used for the identification of the batch number of the drug while the time identification unit for the identification of the expiry date of the drug, quickly making the consumers understanding the manufacturing batch number and the expiry date of the drug through reading the identification labels so as to effectively control the quality and conservation of drugs.

The present invention is a system and method of pre-delivery drug identification. The system and method is implemented where drugs are being administered, such as in a hospital or clinic, and identifies the drug being administered to the patient before the drug reaches the patient. After identification, the system and method is configured to cross-reference the identified drug with the patient's prescription and allergy information, and to prevent delivery to the patient, if necessary.

A method of providing items required for a complex drug regimen. In a preferred embodiment the method includes the steps of disposing a plurality of different drugs in corresponding drug compartments within a container; and providing drug identification information visually associated with each drug compartment containing a drug. The invention also includes a kit for a complex drug regimen. In a preferred embodiment the kit includes a kit container including a plurality of drug compartments, each drug compartment adapted to contain a drug; a plurality of different drugs disposed in the drug compartments; and drug identification information visually associated with each drug compartment containing a drug.

A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds is disclosed. A tunable medical laser diode system for activating PhotoDynamic Therapy (PDT) compounds and other moderate or low energy multiple wavelength applications is disclosed. Interchangeable diode laser cartridges are used. Each cartridge contains a diode laser, which consists of at least one diode or diode array or some combination thereof. Typically, each diode laser cartridge is tuned to a different wavelength. Multiple cartridges, however may be tuned to the same wavelength for some applications One or more cartridges are attached to the system base unit simultaneously. The cartridges may be powered in series or in tandem for different applications. Selectively powering these cartridges causes light to be emitted at a certain wavelength or wavelengths. Selection of cartridges is facilitated by a drug identification scanner which scans drug activation wavelength information into the system. The wavelength can then be changed by selecting different cartridge(s) with diodes operating at other wavelengths. Applicator fiber parameters are recognized by the system as are power output and energy density. Modifications of input power are made accordingly. On a finer scale, tuning can be accomplished using a Master Oscillator Power Amplifier (MOPA). Still Finer tuning can be done by adjustment of system operating temperature. The ability to vary output wavelengths allows for multiple PDT compounds to be activated by one laser system. Other medical applications, such as aiding coagulation, may also be performed with diode lasers using the present invention, while retaining the inherent advantages of diode lasers, i.e., simplicity, low cost, and ease of maintenance.

Nucleotide sequences and the corresponding polypeptide sequences implicated in the regulation of angiogenesis are identified. The nucleotide and polypeptide sequences, or pharmaceutical compositions made from such sequences, can be used in the clinical study of the angiogenesis process, the prognosis, diagnosis and treatment of pathologies linked to angiogenesis, and in the implementation of pharmacological, pharmacogenomic and drug identification trials.

A drug recognition method based on biomedical knowledge map reasoning comprises the following steps of S1, downloading the biomedical text data; S2 constructing a biomedical knowledge map; S3 constructing a drugs-target-disease relationship data set; S4 using a graph embedding method to learn graph representation; 5 training a drug discovery model based on a long-short memory neural network; S6 performing a drug identification step by using the trained model. The method of the invention is applicable to searching for potential therapeutic drugs for diseases, and is not limited to diseases andtypes of drugs, and has great significance to discover drugs that can be used to treat diseases from the literature.

The invention discloses a method of quickly screening pesticides, drugs and converting products in waste water at the same time, belonging to the field of analytical chemistry. The method comprises the following steps: (a) carrying out analytic detection, namely analytically detecting a sample; (b) carrying out pesticide and drug identification, namely screening by adopting pesticide and drug database software to identify whether pesticides and drugs exist or not; and (c) carrying out identifying-non-targeted screening of the converting products, namely predicting the converting products of identified pesticides and drugs in the step (b) through software, carrying out secondary spectrogram analysis and compound screening on an index compound of pesticides and drugs to predict diagnostic ions, and analyzing and identifying the converting products by extracting corresponding chromatographic peaks on the compound comprising the diagnostic ions. According to the method, pesticides, drugs and converting products in waste water can be screened at the same time, and the screening speed is high, the range is wide and the accuracy is high.

The preset invention relates to a process for discovering potential treatment strategy for a given disease, providing a niche for PPI network construction, target prioritization, and potential drug identification for a given disease, particular a cancer, based on the interaction between prioritized NPC targets (e.g. cliques and bottleneck genes) and drugs.

A pharmacy care manager (PCM) uses a reference price for a given drug that reflects the actual cost and availability of the drug in the market. The PCM determines a reference price index (RPI) using drug pricing and availability data from drug manufacturers, wholesalers, pharmacies, and the like, updated on a daily basis. Drug identification data obtained from industry publishers allow pharmaceutical products from different sources to be cross referenced. The PCM then uses the RPI as the basis for the reference price, thereby removing any arbitrariness or inconsistency in the reference price. The reference price may then be applied to pay pharmacy claims and request reimbursements from plan clients. Such an arrangement reduces or eliminates any differences between payment of claims and reimbursement.

The invention discloses a quality control method for Xiaochuanning Pian (a tablet for treating asthma), to which drug identification and content determination are added. The method can identify the active compositions of Chinese ephedra, fructus schisandrae chinensis and radix polygalae and determine the content of Chinese ephedra to improve the exclusiveness and effectiveness of the quality control, thus being beneficial for the effective quality control of the finished Xiaochuanning Pian.

The invention discloses a method and a system for supervising online drug sales based on a database. The method comprises the following steps: obtaining a registration application of an online pharmacy and verifying the registration application; Successful registration of online pharmacies with approved registration requests; Storing the online pharmacy information with a successful registration mark into a pharmacy database; Determining at least one merchandise to be sold of an online pharmacy having a registration success mark, and setting drug identification information for each drug, and storing drug identification information and trade information for each drug in a drug database; Obtaining a trade request for the target drug; When the online pharmacy of the target drug has a successful registration mark, the drug identification information and the trading information of the target drug are verified; When the drug identification information of the target drug passes the verification and the trading status of the target drug is unsold, the target drug is sold; And change the trading status of the target drug to sold.

The invention discloses a drug identification method based on an improved SURF algorithm. The method comprises the steps that a drug bag image is acquired; constructing a Hessian matrix to generate interest points; constructing a scale space; positioning feature points; distributing main directions of the feature points; generating a feature point descriptor; carrying out initial extraction on thefeature points through an Euclidean distance, then screening the feature points through cosine similarity, if the cosine value ratio between two vectors is measured to be smaller than a set thresholdvalue, screening out the feature points, and otherwise, reserving the feature points; and finally, using template matching to complete drug auditing identification, i.e., selecting a template most similar to the detection image according to the matching number of the detected drug bag image and the template image matching points, wherein the type of the template is the type of the detection drugbag image. According to the method, the experimental environment during drug auditing and matching is comprehensively considered, the matching and recognition accuracy of drug bag features is high, and the method has good robustness and high matching speed in rotation and illumination.

The invention discloses a drug classification method, device and equipment and a storage medium, and relates to the field of artificial intelligence technology deep learning and knowledge maps. According to the invention, the specific implementation scheme is that the method comprises the steps: obtaining drug identifiers of to-be-classified drugs; based on the drug identifier and a pre-trained drug classification model, determining a classification label of the to-be-classified drug. According to the invention, related data of drug identification is input into a pre-trained drug classification model; the classification labels are output by the medicine classification model, so the process of manually classifying the medicines is avoided, the problem that the classification labels of the multi-component compound medicines cannot be determined due to the fact that the classification labels are determined according to the medicine components in the prior art is solved, and the medicine classification efficiency and accuracy are effectively improved. The scheme can adopt a cloud service mode and is specifically applied to the aspect of medical big data.

The invention is suitable for the technical field of drug management and provides a cold chain tracing management method and system. The method comprises steps of updating an input mapping relation table among the drug identification number of a to-be-delivered drug, a target cold storage device and the delivery batch; timely collecting and storing a data message uploaded by each cold storage device; and when a query instruction is received, finding temperature data matching conditions from a database and transmitting the query instruction to a client. According to the invention, mobile temperature collection modules are used for temperature informatization establishment of all links of storage and delivery, safety control of internal storage, delivery and transshipment of an enterprise and real-time monitor of circulation links are achieved, and the object of tracing and recalling drugs which need refrigeration is achieved.